Purpose
to reduce the incidence of Rift Valley fever by developing one vaccine that can protect a variety of susceptible species including humans and cattle using a defective simian adenovirus as a safe vector that is easy and cheap to manufacture.
Grantee
Division
Global Health
Date
OCTOBER 2013
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
19
Grantee location
Oxford, United Kingdom
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.